Bioavailability Study of Oxandrolone Tablets Under Fasting Conditions

Inclusion Criteria: * Healthy subject at least 18 years of age, may be male or they may be female who are unable to bear children. * Each subject shall be given a general physical examination within 28days of the initiation study. * At the end of the study, the subjects will have an exit evaluation consisting of interim history, global evaluation, and clinical laboratory measurements. * Each female subject will be given a serum test as part of the pregnancy study screening process. * Clinical laboratory measurements will include Hematology, Clinical Chemistry, Urine Analysis, HIV Screen,hepatitis-B, C screen and Drugs of abuse Screen Exclusion Criteria: * Subjects with a history of alcoholism or drug addiction(during past 2 years), or serious gastrointestinal, renal hepatic or cardiovascular disease, tuberculosis, epilepsy. asthma, diabetes, psychosis or glaucoma will not be eligible for thsi study. * Subjects with any history of breast or prostate cancer will not be eligible to participate in this study. * Subjects who have a history of allergic response to the class of drug being tested will be excluded from the study. * Subjects found to have urine/saliva concentration of any of the tested drugs will not be allowed to participate. * Subjects who have taken any investigational drug within thirty days prior to the first dosing of the study will not be allowed to participate. * Female subjects who are not able to bear children will not be allowed to participate. * Female subjects with positive or inconclusive results will be withdrawn from the study.